Literature DB >> 20285264

The importance of blood changes in coronary occlusion.

W M CAMERON, J H B HILTON.   

Abstract

Entities:  

Keywords:  CORONARY VESSELS/occlusion

Mesh:

Year:  1947        PMID: 20285264      PMCID: PMC1591950     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  CLINICAL STUDIES OF THE BLOOD VOLUME. I. CLINICAL APPLICATION OF A METHOD EMPLOYING THE AZO DYE "EVANS BLUE" AND THE SPECTROPHOTOMETER.

Authors:  J G Gibson; W A Evans
Journal:  J Clin Invest       Date:  1937-05       Impact factor: 14.808

2.  The Effect of the Synthetic Haemorrhagic Agent, 3,3'-Methylenebis (4-Hydroxycoumarin), in Prolonging the Coagulation and Prothrombin Time in the Human Subject.

Authors:  S R Townsend; E S Mills
Journal:  Can Med Assoc J       Date:  1942-03       Impact factor: 8.262

3.  A Test for Increased Coagulability of the Blood.

Authors:  T R Waugh; D W Ruddick
Journal:  Can Med Assoc J       Date:  1944-06       Impact factor: 8.262

4.  BLOOD VOLUME IN CLINICAL SHOCK. I. MIXING TIME AND DISAPPEARANCE RATE OF T-1824 IN NORMAL SUBJECTS AND IN PATIENTS IN SHOCK; DETERMINATION OF PLASMA VOLUME IN MAN FROM 10-MINUTE SAMPLE.

Authors:  R P Noble; M I Gregersen; P M Porter; A Buckman
Journal:  J Clin Invest       Date:  1946-03       Impact factor: 14.808

  4 in total
  3 in total

1.  The questionable importance of blood changes in coronary occlusion.

Authors:  J H B HILTON; W M CAMERON
Journal:  Can Med Assoc J       Date:  1948-11       Impact factor: 8.262

2.  Problems involved in the use of dicoumarol in acute coronary thrombosis.

Authors:  J H B HILTON; W M CAMERON
Journal:  Can Med Assoc J       Date:  1949-04       Impact factor: 8.262

3.  Blood volume studies in shock resulting from myocardial infarction. I. Studies with Evans blue dye (T-1824).

Authors:  C M AGRESS; M ROSENBURG; A SCHNEIDERMAN; E J BROTMAN
Journal:  J Clin Invest       Date:  1950-10       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.